Results 121 to 130 of about 34,587 (240)

Helix-loop transcription factor, Id1, is overexpressed in medullary thyroid cancer [PDF]

open access: bronze, 2000
Electron Kebebew   +3 more
openalex   +1 more source

Draft of clinical guidelines for the diagnosis and treatment of medullary thyroid cancer in adult patients [PDF]

open access: diamond, 2023
N. V. Severskaya   +39 more
openalex   +1 more source

Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations

open access: green, 2014
Thereasa A. Rich   +12 more
openalex   +2 more sources

Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF) [PDF]

open access: gold
Sophie Leboulleux   +20 more
openalex   +1 more source

A phase 1 study of oral LOXO 292 in adult patients with advanced solid tumors, including RET-fusion non-small cell lung cancer, medullary thyroid cancer and other tumors with increased RET activity [PDF]

open access: bronze, 2017
Alexander Drilon   +11 more
openalex   +1 more source

Figure S2 from Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer [PDF]

open access: gold, 2023
Rozita Bagheri‐Yarmand   +6 more
openalex   +1 more source

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

open access: green, 2010
Samuel A. Wells   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy